National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Esophageal Cancer Screening (PDQ®)     
Last Modified: 04/03/2008
Health Professional Version
Summary of Evidence

Benefits
Harms

Note: Separate PDQ summaries on Esophageal Cancer Prevention 1, Esophageal Cancer Treatment 2, and Levels of Evidence for Cancer Screening and Prevention Studies 3 are also available.

Benefits

Based on fair evidence, screening would result in no (or minimal) decrease in mortality from esophageal cancer in the U.S. population.

Description of the Evidence

  • Study Design: Evidence from cohort or case-control studies.
  • Internal Validity: Fair.
  • Consistency: Multiple studies.
  • Magnitude of Effects on Health Outcomes: Small positive.
  • External Validity: Poor.
Harms

Based on solid evidence, screening would result in uncommon but serious side effects associated with endoscopy which may include perforation, cardiopulmonary events and aspiration, and bleeding requiring hospitalization. Potential psychological harms may occur in those identified as having Barrett esophagus who may consider themselves to be ill even though their risk of developing cancer is low.

Description of the Evidence

  • Study Design: Evidence obtained from cohort or case-control studies.
  • Internal Validity: Fair.
  • Consistency: Multiple studies, large number of participants.
  • Magnitude of Effects on Health Outcomes: Fair evidence for no reduction in mortality; good evidence for uncommon but serious harms.
  • External Validity: Poor.


Table of Links

1http://www.cancer.gov/cancertopics/pdq/prevention/esophageal/HealthProfessional
2http://www.cancer.gov/cancertopics/pdq/treatment/esophageal/HealthProfessional
3http://www.cancer.gov/cancertopics/pdq/screening/levels-of-evidence/HealthProfe
ssional